Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
BioVie ( (BIVI) ) has provided an update.
BioVie Inc., a clinical-stage company developing treatments for chronic conditions, has successfully closed a direct offering and private placement, raising approximately $6 million. The funds will be primarily used for working capital and general corporate purposes. This strategic financial move reflects BioVie’s ongoing commitment to advancing its innovative drug therapies, including those for neurodegenerative disorders and liver disease, amidst market uncertainties and potential risks.
See more insights into BIVI stock on TipRanks’ Stock Analysis page.